|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.750 MYR | +0.27% |
|
-1.06% | +7.14% |
| 06-10 | Malaysian Shares Rebound Despite Downbeat Regional Performance; Tanco's Shares Dive 38% | MT |
| 06-10 | Scientex's Profit Jumps in Fiscal Q3 | MT |
| Fiscal Period: July | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 7.54 | 6.61 | 6.85 | 7.7 | 6.37 | |||||
Return on Total Capital | 9.1 | 8.02 | 8.42 | 9.55 | 7.68 | |||||
Return On Equity % | 16.6 | 13.51 | 12.99 | 14.94 | 13.46 | |||||
Return on Common Equity | 16.76 | 13.65 | 13.48 | 15.21 | 13.44 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 23.07 | 21.21 | 21.82 | 22.54 | 23.38 | |||||
SG&A Margin | 7.07 | 7.19 | 7.05 | 6.49 | 7.35 | |||||
EBITDA Margin % | 18.92 | 16.8 | 17.71 | 18.92 | 19 | |||||
EBITA Margin % | 16 | 14.02 | 14.76 | 16.05 | 16.03 | |||||
EBIT Margin % | 16 | 14.02 | 14.76 | 16.05 | 16.03 | |||||
Income From Continuing Operations Margin % | 13.29 | 10.85 | 11.01 | 12.72 | 12.51 | |||||
Net Income Margin % | 12.51 | 10.28 | 10.75 | 12.18 | 11.75 | |||||
Net Avail. For Common Margin % | 12.51 | 10.28 | 10.75 | 12.18 | 11.75 | |||||
Normalized Net Income Margin | 9.49 | 8.03 | 8.45 | 9.64 | 9.41 | |||||
Levered Free Cash Flow Margin | 4.15 | 9.37 | 5.14 | 8.22 | 9.26 | |||||
Unlevered Free Cash Flow Margin | 4.34 | 9.69 | 5.65 | 8.54 | 9.57 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.75 | 0.75 | 0.74 | 0.77 | 0.64 | |||||
Fixed Assets Turnover | 2.69 | 2.79 | 2.69 | 2.9 | 2.85 | |||||
Receivables Turnover (Average Receivables) | 5.87 | 5.77 | 5.26 | 4.74 | 4.55 | |||||
Inventory Turnover (Average Inventory) | 3.77 | 3.86 | 3.82 | 4.08 | 3.8 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.23 | 1.06 | 1.23 | 1.25 | 1.03 | |||||
Quick Ratio | 0.6 | 0.51 | 0.62 | 0.68 | 0.58 | |||||
Operating Cash Flow to Current Liabilities | 0.45 | 0.41 | 0.48 | 0.45 | 0.37 | |||||
Days Sales Outstanding (Average Receivables) | 62.15 | 63.27 | 69.44 | 77.28 | 80.27 | |||||
Days Outstanding Inventory (Average Inventory) | 96.87 | 94.6 | 95.55 | 89.68 | 96.11 | |||||
Average Days Payable Outstanding | 60.45 | 66.67 | 69.2 | 62.21 | 63.8 | |||||
Cash Conversion Cycle (Average Days) | 98.58 | 91.19 | 95.79 | 104.74 | 112.58 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 36.41 | 35.59 | 23.4 | 23.46 | 55.74 | |||||
Total Debt / Total Capital | 26.69 | 26.25 | 18.96 | 19 | 35.79 | |||||
LT Debt/Equity | 9.83 | 7.66 | 2.03 | 1.81 | 24.21 | |||||
Long-Term Debt / Total Capital | 7.2 | 5.65 | 1.64 | 1.46 | 15.54 | |||||
Total Liabilities / Total Assets | 39.27 | 39.58 | 34.49 | 34.82 | 45.66 | |||||
EBIT / Interest Expense | 52.51 | 27.33 | 17.94 | 31.79 | 32.2 | |||||
EBITDA / Interest Expense | 62.41 | 32.93 | 21.64 | 37.64 | 38.34 | |||||
(EBITDA - Capex) / Interest Expense | 51.22 | 23.9 | 17.97 | 33.58 | 27.94 | |||||
Total Debt / EBITDA | 1.62 | 1.75 | 1.16 | 1.11 | 2.83 | |||||
Net Debt / EBITDA | 1.27 | 1.46 | 0.93 | 0.81 | 2.32 | |||||
Total Debt / (EBITDA - Capex) | 1.98 | 2.41 | 1.4 | 1.24 | 3.89 | |||||
Net Debt / (EBITDA - Capex) | 1.55 | 2.02 | 1.12 | 0.91 | 3.18 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 3.9 | 9.01 | 2.3 | 9.78 | 0.94 | |||||
Gross Profit, 1 Yr. Growth % | 4.78 | 0.21 | 5.25 | 13.42 | 4.71 | |||||
EBITDA, 1 Yr. Growth % | 2.35 | -3.21 | 7.85 | 17.29 | 1.37 | |||||
EBITA, 1 Yr. Growth % | 2.9 | -4.47 | 7.73 | 19.35 | 0.82 | |||||
EBIT, 1 Yr. Growth % | 2.9 | -4.47 | 7.73 | 19.35 | 0.82 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 16.21 | -10.95 | 3.78 | 26.78 | -0.72 | |||||
Net Income, 1 Yr. Growth % | 17.2 | -10.36 | 6.9 | 24.44 | -2.65 | |||||
Normalized Net Income, 1 Yr. Growth % | 11.15 | -7.81 | 7.7 | 25.23 | -1.48 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 16.97 | -10.41 | 6.89 | 24.42 | -2.88 | |||||
Accounts Receivable, 1 Yr. Growth % | 22.32 | 1.68 | 22.7 | 21.13 | -8.07 | |||||
Inventory, 1 Yr. Growth % | 14.98 | 3.85 | 1.26 | 2.33 | 12.16 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 4.34 | 5.83 | 6.44 | -2.23 | 7.37 | |||||
Total Assets, 1 Yr. Growth % | 10.86 | 7.35 | 0.56 | 11.78 | 31.13 | |||||
Tangible Book Value, 1 Yr. Growth % | 15.3 | 8.42 | 11.08 | 12.44 | 10.01 | |||||
Common Equity, 1 Yr. Growth % | 13.05 | 7.39 | 9.09 | 11.32 | 9.21 | |||||
Cash From Operations, 1 Yr. Growth % | -2.2 | 5.53 | 9.01 | 6.75 | 5.81 | |||||
Capital Expenditures, 1 Yr. Growth % | -7.26 | 48.04 | -33.28 | -25.55 | 155.04 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -61.81 | 146.06 | -43.91 | 75.71 | 13.67 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -61.05 | 143.32 | -40.33 | 65.86 | 13.14 | |||||
Dividend Per Share, 1 Yr. Growth % | 17.34 | 0 | 11.11 | 20 | 0 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 6.1 | 6.43 | 5.6 | 5.97 | 5.27 | |||||
Gross Profit, 2 Yr. CAGR % | 11.05 | 2.47 | 2.7 | 9.26 | 8.98 | |||||
EBITDA, 2 Yr. CAGR % | 10.8 | -0.47 | 2.17 | 12.47 | 9.04 | |||||
EBITA, 2 Yr. CAGR % | 11.42 | -0.85 | 1.45 | 13.39 | 9.69 | |||||
EBIT, 2 Yr. CAGR % | 11.42 | -0.85 | 1.45 | 13.39 | 9.69 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 18.51 | 1.73 | -3.87 | 14.71 | 12.19 | |||||
Net Income, 2 Yr. CAGR % | 17.06 | 2.5 | -2.11 | 15.33 | 10.06 | |||||
Normalized Net Income, 2 Yr. CAGR % | 13.5 | 1.23 | -0.35 | 16.14 | 11.08 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 15.22 | 2.37 | -2.14 | 15.32 | 9.93 | |||||
Accounts Receivable, 2 Yr. CAGR % | 7.21 | 11.52 | 11.7 | 21.91 | 5.53 | |||||
Inventory, 2 Yr. CAGR % | 6.35 | 9.27 | 2.54 | 1.79 | 7.14 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 5.46 | 5.08 | 6.13 | 2.01 | 2.46 | |||||
Total Assets, 2 Yr. CAGR % | 11.43 | 9.09 | 3.9 | 6.02 | 21.07 | |||||
Tangible Book Value, 2 Yr. CAGR % | 15.21 | 11.81 | 9.74 | 11.76 | 11.22 | |||||
Common Equity, 2 Yr. CAGR % | 14.08 | 10.18 | 8.24 | 10.2 | 10.26 | |||||
Cash From Operations, 2 Yr. CAGR % | 12.07 | 1.59 | 7.26 | 7.87 | 6.28 | |||||
Capital Expenditures, 2 Yr. CAGR % | 19.32 | 17.17 | -0.62 | -29.52 | 37.8 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 116.3 | -3.05 | 17.49 | -0.72 | 41.33 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 164.26 | -2.65 | 20.49 | -0.52 | 36.99 | |||||
Dividend Per Share, 2 Yr. CAGR % | 16.16 | 8.32 | 5.41 | 15.47 | 9.54 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 11.99 | 7.06 | 5.03 | 6.98 | 4.27 | |||||
Gross Profit, 3 Yr. CAGR % | 18.16 | 7.31 | 3.39 | 6.15 | 7.72 | |||||
EBITDA, 3 Yr. CAGR % | 18.5 | 5.92 | 2.23 | 6.98 | 8.64 | |||||
EBITA, 3 Yr. CAGR % | 19.35 | 5.85 | 1.93 | 7.09 | 9.03 | |||||
EBIT, 3 Yr. CAGR % | 19.35 | 5.85 | 1.93 | 7.09 | 9.03 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 18.94 | 7.74 | 2.41 | 5.42 | 9.32 | |||||
Net Income, 3 Yr. CAGR % | 17.13 | 7.09 | 3.95 | 6.04 | 9 | |||||
Normalized Net Income, 3 Yr. CAGR % | 16.86 | 5.9 | 3.34 | 7.54 | 9.94 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 14.79 | 5.95 | 3.85 | 6.01 | 8.9 | |||||
Accounts Receivable, 3 Yr. CAGR % | 12.36 | 5.33 | 15.13 | 14.76 | 10.96 | |||||
Inventory, 3 Yr. CAGR % | 17.16 | 5.51 | 6.53 | 2.47 | 5.14 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 6.45 | 5.58 | 5.53 | 3.27 | 3.77 | |||||
Total Assets, 3 Yr. CAGR % | 14.64 | 10.05 | 6.17 | 6.46 | 13.8 | |||||
Tangible Book Value, 3 Yr. CAGR % | 14.89 | 12.9 | 11.56 | 10.63 | 11.18 | |||||
Common Equity, 3 Yr. CAGR % | 18.29 | 11.8 | 9.82 | 9.25 | 9.87 | |||||
Cash From Operations, 3 Yr. CAGR % | 21.25 | 9.85 | 4.01 | 7.09 | 7.18 | |||||
Capital Expenditures, 3 Yr. CAGR % | 22.46 | 28.21 | -2.88 | -9.74 | 8.2 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 53.66 | 125.8 | -19.22 | 34.36 | 3.86 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 48.41 | 157.09 | -17.31 | 34.03 | 3.84 | |||||
Dividend Per Share, 3 Yr. CAGR % | 10.5 | 10.5 | 9.24 | 10.06 | 10.06 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 10.68 | 10.65 | 9.39 | 6.63 | 5.13 | |||||
Gross Profit, 5 Yr. CAGR % | 12.07 | 11.38 | 11.71 | 8.08 | 5.59 | |||||
EBITDA, 5 Yr. CAGR % | 13.44 | 11.27 | 11.67 | 8.49 | 4.9 | |||||
EBITA, 5 Yr. CAGR % | 13.27 | 11.15 | 11.84 | 8.8 | 4.97 | |||||
EBIT, 5 Yr. CAGR % | 13.27 | 11.15 | 11.84 | 8.8 | 4.97 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 14.52 | 10.72 | 9.23 | 10.47 | 6.21 | |||||
Net Income, 5 Yr. CAGR % | 13.68 | 9.88 | 9.02 | 10.32 | 6.35 | |||||
Normalized Net Income, 5 Yr. CAGR % | 13.32 | 10.45 | 9.65 | 9.88 | 6.37 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 10.82 | 7.66 | 7.69 | 9.6 | 6.24 | |||||
Accounts Receivable, 5 Yr. CAGR % | 16.71 | 12.56 | 12.09 | 11.68 | 11.19 | |||||
Inventory, 5 Yr. CAGR % | 20.7 | 19.96 | 11.08 | 4.01 | 6.77 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 7.82 | 7.72 | 6.32 | 4.14 | 4.29 | |||||
Total Assets, 5 Yr. CAGR % | 17.77 | 16.26 | 10.21 | 8.42 | 11.89 | |||||
Tangible Book Value, 5 Yr. CAGR % | 17.13 | 12.78 | 12.8 | 12.44 | 11.43 | |||||
Common Equity, 5 Yr. CAGR % | 19.76 | 15.16 | 14.16 | 11.16 | 9.99 | |||||
Cash From Operations, 5 Yr. CAGR % | 12.96 | 17.99 | 15.45 | 9.06 | 4.91 | |||||
Capital Expenditures, 5 Yr. CAGR % | -15.37 | 7.62 | 12.65 | 0.92 | 11.71 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 140.81 | 135.78 | 38.01 | 62.55 | 1.04 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 72.41 | 94.44 | 36.54 | 75.85 | 1.19 | |||||
Dividend Per Share, 5 Yr. CAGR % | 11.05 | 11.05 | 8.44 | 12.46 | 9.36 |
- Stock Market
- Stocks
- SCIENTX Stock
- Financials Scientex
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















